中国汉族人群LIPA rs1051338位点多态性与非酒精性脂肪性肝病发病风险的相关性分析
Correlation Analysis of LIPA rs1051338 and Risk of Non-Alcoholic Fatty Liver Disease in Chinese Han Population
DOI: 10.12677/acm.2024.1451631, PDF,   
作者: 李梦昆:青岛大学医学部,山东 青岛;杜水仙*:青岛市市立医院感染性疾病科,山东 青岛
关键词: 非酒精性脂肪性肝病基因多态性LIPA rs1051338Nonalcoholic Fatty Liver Disease Gene Polymorphism LIPA rs1051338
摘要: 目的:非酒精性脂肪性肝病(Non-alcoholic fatty liver disease, NAFLD)是最重要的慢性肝脏疾病,其发生发展受遗传等因素影响。国外研究报道LIPA rs1051338是影响NAFLD发生的潜在位点,但在中国人群中尚未有报道。本研究拟探讨LIPA基因rs1051338位点多态性与中国北方汉族人群NAFLD发生风险的相关性,并揭示其对于血脂等指标的影响。方法:本研究采用病例对照研究方法,对比NAFLD组与健康对照组间LIPA rs1051338位点的等位基因及基因型分布之间的差异,并通过logistic回归模型分析LIPA rs1051338位点基因多态性与NAFLD易感性的关系。对比不同基因型携带者之间临床资料间的差异揭示该位点突变对于各种指标的影响。结果:LIPA rs1051338位点的等位基因和基因型在NAFLD组和健康对照组间的分布均无显著差异(P= 0.195和0.434)。二元logistic回归模型分析LIPA rs1051338位点基因多态性与NAFLD发生风险无显著相关。在全部受试者和NAFLD患者中,CA/CC基因型携带者的SBP、DBP和LDL水平较AA基因型携带者明显升高(P均<0.05)。结论:在我国北方汉族人群中,LIPA基因rs1051338位点多态性与NAFLD发生风险不具有相关性。在全部受试者和NAFLD患者中,CA/CC基因型携带者的SBP、DBP和LDL水平较AA基因型携带者明显升高。
Abstract: Objective: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver diseases, and its occurrence and development are influenced by genetic factors. Foreign studies showed that LIPA rs1051338 was associated with the risk of NAFLD, but no related studies were reported in China. This study aims to explore the correlation between LIPA rs1051338 polymorphism and the risk of NAFLD in northern Han population China, and to reveal its influence on lipid and other indicators. Methods: A case-control study was conducted to compare the distribution of alleles and genotypes of LIPA rs1051338 between NAFLD group and healthy control group, and the relationship between LIPA rs1051338 polymorphism and the risk of NAFLD was analyzed by logistic regression model. Comparison of clinical data between carriers of different genotypes revealed the effect of LIPA rs1051338 polymorphism on various indicators. Results: There was no significant difference in the distribution of alleles and genotypes of LIPA rs1051338 between NAFLD group and healthy control group (P = 0.195 and 0.434). There was no significant correlation between LIPA rs1051338 polymorphism and the risk of NAFLD by binary logistic regression analysis. In all subjects and NAFLD patients, the levels of SBP, DBP and LDL in CA/CC genotype carriers were significantly higher than those in AA genotype carriers (all P < 0.05). Conclusion: There is no correlation between LIPA rs1051338 polymorphism and the risk of NAFLD in northern Han population, China. In all subjects and NAFLD patients, the levels of SBP, DBP and LDL in CA/CC genotype carriers were significantly higher than those in AA genotype carriers.
文章引用:李梦昆, 杜水仙. 中国汉族人群LIPA rs1051338位点多态性与非酒精性脂肪性肝病发病风险的相关性分析[J]. 临床医学进展, 2024, 14(5): 1891-1901. https://doi.org/10.12677/acm.2024.1451631

参考文献

[1] Lonardo, A., Byrne, C.D., Caldwell, S.H., et al. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease: Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 1388-1389. [Google Scholar] [CrossRef] [PubMed]
[2] Doycheva, I., Issa, D., Watt, K.D., et al. (2018) Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. Journal of Clinical Gastroenterology, 52, 339-346. [Google Scholar] [CrossRef
[3] Zhu, J.Z., Zhou, Q.Y., Wang, Y.M., et al. (2015) Prevalence of Fatty Liver Disease and the Economy in China: A Systematic Review. World Journal of Gastroenterology, 21, 5695-5706. [Google Scholar] [CrossRef] [PubMed]
[4] Younossi, Z.M., Golabi, P., Paik, J.M., et al. (2023) The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology, 77, 1335-1347. [Google Scholar] [CrossRef
[5] Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism: Clinical and Experimental, 65, 1038-1048. [Google Scholar] [CrossRef] [PubMed]
[6] Zechner, R., Madeo, F. and Kratky, D. (2017) Cytosolic Lipolysis and Lipophagy: Two Sides of the Same Coin. Nature Reviews Molecular Cell Biology, 18, 671-684. [Google Scholar] [CrossRef] [PubMed]
[7] Shen, F., Zheng, R.D., Mi, Y.Q., et al. (2014) Controlled Attenuation Parameter for Non-Invasive Assessment of Hepatic Steatosis in Chinese Patients. World Journal of Gastroenterology, 20, 4702-4711. [Google Scholar] [CrossRef] [PubMed]
[8] Korbelius, M., Kuentzel, K.B., Bradić, I., et al. (2023) Recent Insights into Lysosomal Acid Lipase Deficiency. Trends in Molecular Medicine, 29, 425-438. [Google Scholar] [CrossRef] [PubMed]
[9] Viaud, M., Ivanov, S., Vujic, N., et al. (2018) Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production. Circulation Research, 122, 1369-1384. [Google Scholar] [CrossRef
[10] Ouimet, M., Franklin, V., Mak, E., et al. (2011) Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid Lipase. Cell Metabolism, 13, 655-667. [Google Scholar] [CrossRef] [PubMed]
[11] Bowden, K.L., Dubland, J.A., Chan, T., et al. (2018) LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 1191-1201. [Google Scholar] [CrossRef
[12] European Association for the Study of the Liver (2015) EASL-ALEH Clinical Practice Guidelines: Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis. Journal of Hepatology, 63, 237-264. [Google Scholar] [CrossRef] [PubMed]
[13] Baratta, F., Pastori, D., Ferro, D., et al. (2019) Reduced Lysosomal Acid Lipase Activity: A New Marker of Liver Disease Severity across the Clinical Continuum of Non-Alcoholic Fatty Liver Disease? World Journal of Gastroenterology, 25, 4172-4180. [Google Scholar] [CrossRef] [PubMed]
[14] Mashima, R. and Takada, S. (2022) Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study. International Journal of Molecular Sciences, 23, Article 15549. [Google Scholar] [CrossRef] [PubMed]
[15] Vargas-Alarcón, G., Posadas-Romero, C., Villarreal-Molina, T., et al. (2013) Single Nucleotide Polymorphisms within LIPA (Lysosomal Acid Lipase A) Gene Are Associated with Susceptibility to Premature Coronary Artery Disease. A Replication in the Genetic of Atherosclerotic Disease (GEA) Mexican Study. PLOS ONE, 8, e74703. [Google Scholar] [CrossRef] [PubMed]
[16] Pasta, A., Borro, P., Cremonini, A.L., et al. (2021) Effect of a Common Missense Variant in LIPA Gene on Fatty Liver Disease and Lipid Phenotype: New Perspectives from a Single-Center Observational Study. Pharmacology Research & Perspectives, 9, e00820. [Google Scholar] [CrossRef] [PubMed]
[17] National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association and Fatty Liver Expert Committee, Chinese Medical Doctor Association (2018) [Guidelines of Prevention and Treatment for Nonalcoholic Fatty Liver Disease: A 2018 Update]. Chinese Journal of Hepatology, 26, 195-203.
[18] Evans, T.D., Zhang, X., Clark, R.E., et al. (2019) Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated with Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 2480-2491. [Google Scholar] [CrossRef
[19] Ahmadian, M., Duncan, R.E., Jaworski, K., et al. (2007) Triacylglycerol Metabolism in Adipose Tissue. Future Lipidology, 2, 229-237. [Google Scholar] [CrossRef] [PubMed]
[20] Boadu, E., Bilbey, N.J. and Francis, G.A. (2008) Cellular Cholesterol Substrate Pools for Adenosine-Triphosphate Cassette Transporter A1-Dependent High-Density Lipoprotein Formation. Current Opinion in Lipidology, 19, 270-276. [Google Scholar] [CrossRef
[21] Oram, J.F. and Heinecke, J.W. (2005) ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter that Protects against Cardiovascular Disease. Physiological Reviews, 85, 1343-1372. [Google Scholar] [CrossRef] [PubMed]
[22] Maxfield, F.R. and Tabas, I. (2005) Role of Cholesterol and Lipid Organization in Disease. Nature, 438, 612-621. [Google Scholar] [CrossRef] [PubMed]
[23] Koga, H., Kaushik, S. and Cuervo, A.M. (2010) Altered Lipid Content Inhibits Autophagic Vesicular Fusion. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 24, 3052-3065. [Google Scholar] [CrossRef] [PubMed]
[24] Emanuel, R., Sergin, I., Bhattacharya, S., et al. (2014) Induction of Lysosomal Biogenesis in Atherosclerotic Macrophages Can Rescue Lipid-Induced Lysosomal Dysfunction and Downstream Sequelae. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1942-1952. [Google Scholar] [CrossRef
[25] Morris, G.E., Braund, P.S., Moore, J.S., et al. (2017) Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1050-1057. [Google Scholar] [CrossRef
[26] Guo, X., Yin, X., Liu, Z., et al. (2022) Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences, 23, Article 15489. [Google Scholar] [CrossRef] [PubMed]
[27] Miura, K., Kodama, Y., Inokuchi, S., et al. (2010) Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice. Gastroenterology, 139, 323-334. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, Z., Tian, R., She, Z., et al. (2020) Role of Oxidative Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Free Radical Biology & Medicine, 152, 116-141. [Google Scholar] [CrossRef] [PubMed]
[29] Guénard, F., Houde, A., Bouchard, L., et al. (2012) Association of LIPA Gene Polymorphisms with Obesity-Related Metabolic Complications among Severely Obese Patients. Obesity, 20, 2075-2082. [Google Scholar] [CrossRef] [PubMed]